A microRNA expression ratio defining the invasive phenotype in bladder tumors (Q39938718)

15 September 2017

A microRNA expression ratio defining the invasive phenotype in bladder tumors (English)

1 reference

15 September 2017

0 references

1 reference

Lori A Neely

1

1 reference

15 September 2017

Kimberly M Rieger-Christ

2

1 reference

15 September 2017

Brasil Silva Neto

3

1 reference

15 September 2017

Alexey Eroshkin

4

1 reference

15 September 2017

Joanne Garver

5

1 reference

15 September 2017

Sonal Patel

6

1 reference

15 September 2017

Nu Ai Phung

7

1 reference

15 September 2017

Stephen McLaughlin

8

1 reference

15 September 2017

John A Libertino

9

1 reference

15 September 2017

Duncan Whitney

10

1 reference

15 September 2017

Ian C Summerhayes

11

1 reference

15 September 2017

16 September 2008

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

39-48

1 reference

15 September 2017

1

1 reference

Urothelial tumorigenesis: a tale of divergent pathways

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Identifying distinct classes of bladder carcinoma using microarrays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Gene expression profiling of noninvasive primary urothelial tumours using microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Bladder cancer stage and outcome by array-based comparative genomic hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Bladder cancer outcome and subtype classification by gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Oncomirs - microRNAs with a role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA signatures in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA biogenesis, functionality and cancer relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

The let-7 microRNA represses cell proliferation pathways in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

miR-21-mediated tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA expression profiling in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA gene expression deregulation in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

A microRNA expression signature of human solid tumors defines cancer gene targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Knowledge discovery in high-dimensional data: case studies and a user survey for the rank-by-feature framework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

A single-molecule method for the quantitation of microRNA gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA expression profiles in head and neck cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNAs and the hallmarks of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Amplification and overexpression of E2F3 in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.06.006

10.1016/J.UROLONC.2008.06.006

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference